LAVA Therapeutics NV

NASDAQ:LVTX 4:00:00 PM EDT

2.83

-0.11 (-3.74%)

4:00:56 PM EDT: $2.82 -0.01 (-0.35%)

Market Cap (Intraday)	74.40M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.33 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$2.99
50-Day MA	$2.67
200-Day MA	$1.89

See more pivots

LAVA Therapeutics NV Stock, NASDAQ:LVTX

Yalelaan 62, Utrecht, Noord-Brabant 3584 CM

Netherlands

Phone: +31.85.016.31.00

Number of Employees: 37

http://www.lavatherapeutics.com

Description

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.